BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Pharmacogenetics
,
Rosiglitazone
,
rs2300478
,
PPARA
,
glucose metabolic process
,
Retina
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
PI3-kinase
Summary
General Info
Curated Studies
Most Correlated Studies
Heart gene expression after myocardial infarction in mice expressing PI3 kinase transgenes
Prostates from polyomavirus middle T antigen transgenic and wildtype FVB mice
Lung cancer HCC827 EGFR-mutant cells following treatment with targeted therapies
HMECs with BEZ235 resistance, expressing a mutant PIK3CA(H1047R) transgene, and treated with BEZ235
CD4+ T cells age and culture condition comparisons treated with rapamycin or LY 294002
Explore Curated Studies Results
Literature
Most Relevant Literature
Anti-apoptotic Effect of MiR-223-3p Suppressing PIK3C2A in Cardiomyocytes from Myocardial Infarction…
PI3KC2α-dependent and VPS34-independent generation of PI3P controls primary cilium-mediated autophag…
Lipid kinase PIK3C3 maintains healthy brown and white adipose tissues to prevent metabolic diseases.
Dendritic cell PIK3C3/VPS34 controls the pathogenicity of CNS autoimmunity independently of LC3-asso…
Synonymous mutation rs1129293 is associated with PIK3CG expression and PI3Kγ activation in patients …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
The Safety, Pharmacokinetic and Pharmacodynamic Effect of KA2237 (PI3 Kinase p110β/δ Inhibitor) In B…
PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib
A Dose Escalation Study of SF1126, a PI3 Kinase (PI3K) Inhibitor, Given By Intravenous (IV) Infusion…
Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors
A Study of PI3-Kinase Inhibitor GDC-0941 in Combination With Paclitaxel, With and Without Bevacizuma…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ